SCHEMBL12590009

SCHEMBL12590009

c1cnc(-n2cnc3cc(-c4cccnc4)ccc32)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ QPCT Q16769 1/20 0.47
▸ QPCTL Q9NXS2 1/20 0.47
▸ GABRA1 P14867 1/20 0.47
▸ GABRG2 P18507 1/20 0.47
▸ GABRB3 P28472 1/20 0.47
▸ GABRA5 P31644 1/20 0.47
▸ GABRA3 P34903 1/20 0.47
▸ GABRA2 P47869 1/20 0.47
▸ CYP2A6 P11509 4/20 0.43
▸ CYP11B1 P15538 4/20 0.43
▸ CYP11B2 P19099 4/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP17A1 P05093 1/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ KDR P35968 1/20 0.42
▸ FGFR1 P11362 2/20 0.41
▸ PLK1 P53350 1/20 0.41
▸ PLK3 Q9H4B4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12590010 0.85 POLB (0.56) QPCTQPCTLGABRA1GABRG2GABRB3
SCHEMBL2646371 0.78 GABRA1 (0.53) QPCTQPCTLGABRA1GABRG2GABRB3
SCHEMBL14668386 0.76 FGFR1 (0.54) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2656285 0.75 GABRA1 (0.58) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2647150 0.75 FGFR1 (0.60) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2646283 0.75 GABRA1 (0.58) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL16035814 0.75 FGFR1 (0.67) ALDH1A1CYP17A1FGFR1RPS6KA5MKNK1
SCHEMBL2644075 0.75 GABRA1 (0.52) QPCTQPCTLGABRA1GABRG2GABRB3
Lithium Ion SCHEMBL17315130 0.75 GABRA1 (0.48) QPCTQPCTLGABRA1GABRG2GABRB3
SCHEMBL17323692 0.75 GABRA1 (0.48) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336122-A1 1-pyrimidinyl- or 1-pyridinyl-2-amino benzimidazole derivatives and related compounds as inhibitors of protein kinases for the treatment of cancer Vertex Pharmaceuticals Incorporated (US) 2011-06-22 — — EP disclosed
Send feedback